piperidines and Myositis-Ossificans

piperidines has been researched along with Myositis-Ossificans* in 1 studies

Other Studies

1 other study(ies) available for piperidines and Myositis-Ossificans

ArticleYear
Successful experience of tofacitinib treatment in patients with Fibrodysplasia Ossificans Progressiva.
    Pediatric rheumatology online journal, 2023, Aug-29, Volume: 21, Issue:1

    Fibrodysplasia ossificans progressive (FOP) is an ultra-rare genetic disorder that is caused by a mutation in the ACVR1 gene and provokes severe heterotopic ossification. Since flares of the disease are associated with inflammation, it is assumed that JAK inhibitors can control active FOP due to blocking multiple signaling pathways.

    Topics: Humans; Inflammation; Myositis Ossificans; Patients; Piperidines; Rare Diseases

2023